Cargando…
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
Coronavirus Disease 2019 (COVID-19) is an infectious illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), originally identified in Wuhan, China (December 2019) and has since expanded into a pandemic. Here, we investigate metabolites present in several common spices as poss...
Autores principales: | Ibrahim, Mahmoud A.A., Abdelrahman, Alaa H.M., Hussien, Taha A., Badr, Esraa A.A., Mohamed, Tarik A., El-Seedi, Hesham R., Pare, Paul W., Efferth, Thomas, Hegazy, Mohamed-Elamir F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543985/ https://www.ncbi.nlm.nih.gov/pubmed/33065388 http://dx.doi.org/10.1016/j.compbiomed.2020.104046 |
Ejemplares similares
-
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Guaianolide Sesquiterpene Lactones from Centaurothamnus maximus
por: Hussien, Taha A., et al.
Publicado: (2021) -
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
por: Ibrahim, Mahmoud A.A., et al.
Publicado: (2021)